Programma

News

June 16, 2016

Mobile technology enables ehealth for care, cure and research

In September this year, leaders from companies such as Pfizer, Otsuka, Quintiles, Roche and Eli Lilly & Co, will convene at the ‘Mobile in Clinical Trials’ event in Boston to discuss the uses and barriers to mobile technology in clinical trials.

Share this article

The combination of mobile devices, wearables, networks and analytics is proving to be an incredible stepping stone towards a more efficient and more personalised healthcare, while at the same time enabling better medical research. Mobile and web-based technology platforms are on the rise for both clinical trials and post-approval programs, writes Perficient, with mobile increasingly being viewed as a key enabler and accelerator for new strategies, treatments and devices.

The broader adoption of mobile technology is expected as clinical trial enablement for recruitment, improved patient-healthcare provider communication, patient experience, electronic data capture, and support for the completion of clinical trial assessments and online patient surveys begins to go mainstream. Apple for example believes that its Apple Watch can become an enabler for better patient care, beter health research an more efficient cure and care providers such as hospitals.

Greater adherence

With a tablet, smart phone or other wireless device, patients are now able to stay engaged with their clinical trial partners for wellness, training and education activities, diagnostic and treatment support, or remote monitoring. This makes it much more easy to adhere to health or research programs.
Leaders in the life science industry, academia, as well as payers and providers alike, are turning to mobile platforms as an efficient and effective way to engage patients, members and customers across the healthcare spectrum as part of daily living, overcoming the technical, regulatory, scientific and cultural barriers to truly capitalize on mobile capability.

Range of issues adressed

Perficient sees mobile innovation across its Health Sciences client portfolio, with clients addressing a range of issues. Some examples are:

•    The pharmaceutical industry and contract research organizations are engaging with patients more directly using mobile technology, leading to the promise of faster study execution and reduced cost.
•     Investigative site staff are using mobile applications for remote data collection, with the resultant benefit to patients in terms of a reduced site visits during trial participation.
•    Healthcare providers are using mobile to deliver telehealth and telemedicine in a variety of ways, one such example is a use case to address post-hospital discharge to remind patients about their follow up appointments, medication, exercise and dietary requirements both to improve outcomes and lower the risk of readmissions.
•    Several leading health plans have already applied mobile strategies  to promote wellness, improve medication adherence, member retention, symptom-to-provider pathways and much more.

Share this article

Don't miss the most exciting developments